Siolta Therapeutics logo

Siolta Therapeutics

Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases. The company was founded in 2016 by Nikole Kimes PhD.

2

Funding Rounds

$30.0m

Money raised

Overview

Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases. The company was founded in 2016 by Nikole Kimes PhD.

Funding series

Funding Series Analysis

The company Siolta Therapeutics has raised a total of $30m in funding over 2 rounds.

Key Insights:

  • Siolta Therapeutics Series B round, September 2020: $30m
Siolta Therapeutics logo
Siolta Therapeutics Series B round, September 2020 $30m